Section 68

EurekaMag Full Text Articles Chapter 67,128


Jolicoeur, F.B.; Barbeau, A.; Rioux, F.; Quirion, R.; St-Pierre, S. 1981: Differential neurobehavioral effects of neurotensin and structural analogues. Peptides 2(2): 171-175
Garciaespinosa, M. 2004: Cerebral glucose metabolism and the glutamine cycle as detected by in vivo and in vitro 13C Nmr spectroscopy. Neurochemistry International 45(2-3): 297-303
Parpura, V. 2004: Mechanisms of glutamate release from astrocytes: gap junction ?hemichannels?, purinergic receptors and exocytotic release. Neurochemistry International 45(2-3): 259-264
Jow, F. 2004: Production of Gaba by cultured hippocampal glial cells. Neurochemistry International 45(2-3): 273-283
Winkler, B. 2004: Cultured retinal neuronal cells and Mller cells both show net production of lactate. Neurochemistry International 45(2-3): 311-320
Mori, T. 2004: Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent Ono-2506. Neurochemistry International 45(2-3): 381-387
Tanga, F. 2004: Quantitative real-time Rt-Pcr assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochemistry International 45(2-3): 397-407
Kielian, T. 2004: Effects of neuroinflammation on glia?glia gap junctional intercellular communication: a perspective. Neurochemistry International 45(2-3): 429-436
Tew, J.G. 1981: Accessory cells in the immune response: Macrophages, dendritic cells, and langerhans cells. Clinical Immunology Newsletter 2(7): 55-57
Stimson, W.H. 1981: Pregnancy-associated serum proteins and hormones: Do they contribute to the regulation of the maternal immune response in pregnancy?. Clinical Immunology Newsletter 2(2): 7-11
Specter, S. 1983: Natural killer (Nk) cell responses in Aids patients. Clinical Immunology Newsletter 4(12): 165-166
Fudenberg, H.H. 1984: Clinical responses to Transfer factor therapy: An update. Clinical Immunology Newsletter 5(8): 109-113
Dziarski, R. 1985: Antibody responses to Staphylococcus aureus cell wall antigens. Clinical Immunology Newsletter 6(4): 58-62
Friedel, R. 2004: Psychodrama in the 21st century: Clinical and Educational Applications Jacob Gershoni (Ed.), Springer Publishing Company, New York, 2003, 312 pages, \$44.95, hardcover. The Arts in Psychotherapy 31(4): 275-276
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1999: The Brenda Model*1, *2A Psychosocial Addiction Model to Identify and Treat Alcohol Disorders in Elders. Geriatric Nursing 20(6): 302-304
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1999: Restraint Reduction*1, *2Research Utilization and Case Study with Cognitive Impairment. Geriatric Nursing 20(6): 305-308
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1999: Two Models of Restorative Nursing Care in the Nursing Home*1Designated Versus Integrated Restorative Nursing Assistants. Geriatric Nursing 20(6): 321-326
Torfs, K.; Feldman, H. 2000: 12-month decline in cognitive and daily function in patients with mild-to-moderate Alzheimer's disease: Two randomized, placebo-controlled studies. Neurobiology of Aging 21: 242-243
Hardy, J. 2004: The uncertain anatomy of Alzheimer?s disease. Neurobiology of Aging 25(6): 719-720
Terry, R. 2004: Tangles precede plaques but don?t cause them. Neurobiology of Aging 25(6): 741-742
Braak, H. 2004: Alzheimer?s disease: intraneuronal alterations precede insoluble amyloid-\$beta; formation. Neurobiology of Aging 25(6): 713-718
Adlard, P. 2004: Alzheimer?s disease?a sum greater than its parts?. Neurobiology of Aging 25(6): 725-733
Alpitsis, R.; Saling, M.; Louis, W. 2004: P2-258 Apolipoprotein E status and memory complaint as risk factors for future memory decline in the normal elderly. Neurobiology of Aging 25: S305-S306
Giliberto, L.; Assini, A.; Cammarata, S.; Colucci, M.; Borghi, R.; Piccini, A.; Odetti, P.; Dagna-Briccarelli, F.; Argusti, A.; Tabaton, M. 2004: P2-261 Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurobiology of Aging 25: S306-S307
Simpson, K.L. 2004: P2-266 Evaluation of selection bias in a community-based dementia autopsy case series. Neurobiology of Aging 25: S307-S308
Schnaider Beeri, M.; Schmeidler, J.; Pulver, E.; Wang, J.; Gruppo, R.; Stroop, D.; Becker, A.; Silverman, J.M. 2004: P2-269 Homocysteine is not associated with memory and language in the nondemented oldest old. Neurobiology of Aging 25: S308-S309
Pawlak, M.A.; Kozubski, W. 2004: P2-272 Publication trends in Alzheimer disease. Neurobiology of Aging 25: S309-S310
Aronson, S.M.; VanBaelen, B.; Kershaw, P. 2004: P2-275 Greater benefits for patients receiving sustained vs. interrupted treatment with galantamine. Neurobiology of Aging 25: S310-S311
Oijen, M.van 2004: P2-282 Leucocyte count, intake of antioxidants and risk of Alzheimer's disease. Neurobiology of Aging 25: S312-S313
Wolf, H.; Wahlund, L.-O.; Müller, U.; Hensel, A.; Gertz, H.-J. 2004: P2-286 Education and intracranial volume are independent predictors of late-life cognitive state. Neurobiology of Aging 25: S313-S314
Barnes, L.L.; Wilson, R.S.; Bienias, J.L.; Schneider, J.A.; Evans, D.A.; Bennett, D.A. 2004: P2-289 Gender differences in the clinical manifestations of Alzheimer's disease pathology. Neurobiology of Aging 25: S314-S315
Wahrle, S.E.; Jiang, H.; Parsadanian, M.; Legleiter, J.; Kowaleski, T.; Holtzman, D.M. 2004: P2-291 Abca1 knock-out mice have decreased apoeinbrainand Csf and secrete cholesterol poor apoE-containing Hdl from astrocytes in vitro. Neurobiology of Aging 25: S315-S316
Sullivan, P.M.; Mace, B.; Thomas, M.; Schmechel, D. 2004: P2-298 Effects of a high fat diet on brain lipid levels in human apoE targeted replacement mice. Neurobiology of Aging 25: S317-S318
Costa, D.A.; Bales, K.R.; Paul, S.M.; Potter, H. 2004: P2-302 Apolipoprotein E is required for filamentous, but not diffuse, amyloid deposition in an App/Ps mouse model of Alzheimer's disease. Neurobiology of Aging 25: S318-S319
Geldmacher, D.S. 2004: P2-306 Stimulus features and eye-movements in Alzheimer disease: effect of Pop-out stimuli. Neurobiology of Aging 25: S319-S320
Noroozian, M.; Noroozian, M. 2004: P2-309 Current status of the elderly population in Iran:. Neurobiology of Aging 25: S320-S321
Zbrozek, A.S.; Gregory, A.; Karlawish, J.; Kinosian, B.; Glick, H. 2004: P2-313 Test/re-test reliability assessment of 6 health status measures in patients with suspected mild to moderate Alzheimer's disease and their proxy caregivers. Neurobiology of Aging 25: S321-S322
Allen, C. 2004: P2-316 Using multi-media to capture the history, views and preferences of older people newly diagnosed with dementia. Neurobiology of Aging 25: S322-S323
Karlawish, J.; Gregory, A.; Zbrozek, A.; Kinosian, B.; Glick, H. 2004: P2-319 Carer responses to generic measures of health related quality of life (Hr Qol) are valid in assessing patients with mild to moderate Alzheimers disease (Ad). Neurobiology of Aging 25: S323-S324
Brandt, N.J.; Loreck, D.; Taylor, J.; Magoon, R. 2004: P2-322 Evaluating the impact of a medication utilization tool for cholinesterase inhibitors. Neurobiology of Aging 25: S324-S325
Rozzini, L.; Cornali, C.; Ghianda, D.; Franzoni, S.; Trabucchi, M.; Padovani, A. 2004: P2-325 Predictors of institutionalization in demented patients discharged from a rehabilitation unit. Neurobiology of Aging 25: S325-S326
Cappa, A.; DeSanctis, S.; Benet, B. 2004: P2-329 The influence of cognition and psychiatric symptoms on activities of daily living and lifestyle in Alzheimer's disease. Neurobiology of Aging 25: S326-S327
Steinberg, M.; Corcoran, C.; Huber, C.; Welsh-Bohmer, K.; Norton, M.; Zandi, P.; Breitner, J.; Tschanz, J.; Lyketsos, C. 2004: P2-333 A longitudinal model for neuropsychiatric symptoms in dementia: the Cache County Study. Neurobiology of Aging 25: S327-S328
Mejia, S.; Miguel, A.; Gutiérrez, L.M.; Villa, A.R.; Ostrosky-Solis, F. 2004: P2-340 Comparative analysis of cognitive impairment among five survey studies in Spanish-speaking elders. Neurobiology of Aging 25: S329-S330
Robbins, J.M.; Salmanson, E.; Rentz, D. 2004: P2-347 Reducing apathy, depression and behavioral dyscontrol in patients with Alzheimer's disease residing in anursing home. Neurobiology of Aging 25: S331-S332
Kulasingam, S.L.; Matchar, D.B.; Schmechel, D. 2004: P2-350 Costs associated with increasing severity of dementia A review of the literature. Neurobiology of Aging 25: S332-S333
Novelli, M.P.; Nitrini, R.; Barham, E.; Caramelli, P. 2004: P2-356 Construct validity of the Brazilian version of the quality of life in Alzheimer's disease evaluation scale (Qol-Ad): preliminary results. Neurobiology of Aging 25: S334-S335
Corder, L.S.; Adler, G.S. 2004: P2-359 New evidence from national surveys: declines in the prevalence of severe cognitive impairment among the U.S. aged population. Neurobiology of Aging 25: S335-S336
Astell, A.J.; Ellis, M.P. 2004: P2-363 Social cognition in Alzheimer's disease. Neurobiology of Aging 25: S336-S337
Fleming, K.; Turner, J.; Alva, G.; Potkin, S.G. 2004: P2-373 Relative sparing of picture learning in Alzheimer's disease. Neurobiology of Aging 25: S339-S340
Ellis, M.P.; Astell, A.J. 2004: P2-376 Maintaining social participation in severe dementia: the potential of imitation. Neurobiology of Aging 25: S340-S341
Alm, N.; Astell, A.J.; Gowans, G.; Campbell, J.; Dye, R.; Ellis, M. 2004: P2-381 Supporting communication in dementia: the potential of hypermedia. Neurobiology of Aging 25: S341-S342
Langa, K.M.; Ubel, P.; Brown, S.; Kabeto, M.; Schulz, R. 2004: P2-385 Depressive symptoms before and after the death of a spouse with dementia. Neurobiology of Aging 25: S342-S343
Campbell, P.; Jones, L.; Bentham, P.; Lendon, C. 2004: P2-388 An investigation of the impact of behavioural and psychological symptoms of dementia (Bpsd) on carer well being. Neurobiology of Aging 25: S343-S344
Drew, J.C. 2004: P2-391 Cultural interpretations of caregiving in dementia. Neurobiology of Aging 25: S344-S345
McSweeney, M.H. 2004: P2-394 The greater Pennsylvania Alzheimers' association rural direct care worker dementia training demonstration: findings and future directions. Neurobiology of Aging 25: S345-S346
Sun, S.W.; Wolf-Klein, G. 2004: P2-401 Complementary and alternative medicine (Cam) use in dementias. Neurobiology of Aging 25: S347-S348
Horikoshi, Y.; Matsuoka, Y.; Yamaguchi, H.; Maeda, M.; Kinoshita, N. 2004: P3-005 The development of amyloid terminal-end specific monoclonal antibodies and high sensitive Elisa systems to detect various kinds of amyloid species. Neurobiology of Aging 25: S352-S353
Kulstad, J.; Green, P.S.; Cook, D.G.; Watson, G.S.; Reger, M.; Cholerton, B.; Baker, L.D.; Plymate, S.R.; Asthana, S.; Fishel, M.; Kahn, S.E.; Craft, S. 2004: P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 140 and 142 in patients with early Alzheimer's disease. Neurobiology of Aging 25: S354-S355
Stefani, A.; Bernardini, S.; Panella, M.; Giordano, A.; Urbani, A.; Biroccio, A.; Federici, G.; Bernardi, G. 2004: P3-020 Differential diagnosis amongst primary degenerative, mixed and vascular dementia: the contribution of the routine Csf title of A 142, T-Tau and P-Tau181. Neurobiology of Aging 25: S356-S357
van de Pol, L.A.; Visser, P.-J.; Schoonenboom, N.; Scheltens, P. 2004: P3-030 Correlation between Csf levels of Tau, Ptau-181, and Abeta42 and the score on the predementia Alzheimer's disease scale (Pas) in subjects with Mci. Neurobiology of Aging 25: S359-S360
Maruyama, M.; Matsui, T.; Tanji, H.; Nemoto, M.; Tomita, N.; Ootsuki, M.; Arai, H.; Sasaki, H. 2004: P3-033 Cerebrospinal fluid Tau and periventricular white matter lesions in stable and progressive mild cognitive impairment. Neurobiology of Aging 25: S360-S361
Wang, J.; Patel, V.; Ren, C.; Zorn, L.; Reagan, K. 2004: P3-040 Development and validation of human A42 assay with specific measurement of human A1-42 in natural samples. Neurobiology of Aging 25: S362-S363
Schuitemaker, A.; Mulder, C.; Schoonenboom, N.S.; Ketema, M.; van Elk, E.-J.; Scheltens, P.; van Kamp, G.J. 2004: P3-043 Inflammatory markers Crp and Il-6 in cerebrospinal fluid and serum in relation to the Il-6 genotype in patients with Alzheimer's disease. Neurobiology of Aging 25: S363-S364
Fagan, A.M.; Christopher, E.; Spinner, M.; Han, X.; Morris, J.C.; Holtzman, D.M. 2004: P3-047 Probing for antecedent biomarkers of Alzheimer's disease through analysis of cerebrospinal fluid from middle-aged individuals. Neurobiology of Aging 25: S364-S365
Green, P.S.; Kulstad, J.J.; Cook, D.G.; Craft, S. 2004: P3-051 Improved detection of plasma beta-amyloid by sandwhich elisa. Neurobiology of Aging 25: S365-S366
Bonte, F.J.; Harris, T.S.; Roney, C.A.; Hynan, L.S. 2004: P3-054 The posterior cingulatesign in spect differential diagnosis of Alzheimer's disease and related disorders. Neurobiology of Aging 25: S366-S367
Rombouts, S.A.; Goekoop, R.; Sachak, S.; Truyen, L.; Barkhof, F.; Scheltens, P. 2004: P3-061 Effects of galantamine on brain activation during episodic memory in Alzheimer's disease. Neurobiology of Aging 25: S368-S369
Scheltens, P.; Rombouts, S.A.; Goekoop, R.; Barkhof, F. 2004: P3-063 Activation in the working memory network in healthy aging, mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging 25: S369-S370
Heidebrink, J.L.; Barbas, N.R.; Scott Turner, R.; Clark, C.M.; Jagust, W.J.; Arnold, S.E.; DeCarli, C.S.; Koeppe, R.A.; Higdon, R.; Foster, N.L. 2004: P3-065 Fdg-Pet improves differential diagnosis of dementia when clinical history and examination are ambiguous. Neurobiology of Aging 25: S370-S371
Zhang, Y.; Wahlund, L.-O. 2004: P3-067 Lean frontal horns ratio a new linear measurement to predict early cerebral atrophy on Ct. Neurobiology of Aging 25: S371-S372
Wang, H.; Nalcioglu, O.; Su, M.-Y. 2004: P3-072 Vascular volume and Bbb permeability in hippocampus and cerebellum measured with dynamic contrast-enhanced Mri in Mci vs. controls. Neurobiology of Aging 25: S373-S374
Skovronsky, D.; Judkins, A.R.; Kung, M.-P.; Forman, M.; Martinez, D.; Hou, C.; Zhuang, Z.-P.; Kung, H.F. 2004: P3-079 Characterization of neurodegenerative disease radioligands by tissue microarray analysis. Neurobiology of Aging 25: S375-S376
Burns, J.M.; Church, J.; Johnson, D.; Xiong, C.; Marcus, D.; Fotenos, A.F.; Snyder, A.Z.; Morris, J.C.; Buckner, R.L. 2004: P3-082 Subclinical brain lesions and cognition in nondemented aging and early-stage Alzheimer disease. Neurobiology of Aging 25: S376-S377
Lee, D.Y.; Jhoo, J.H.; Choo, I.H.; Kim, K.W.; Yoon, J.C.; Lee, D.S.; Woo, J.I. 2004: P3-085 Increased cerebellar glucose metabolism in the depressive Alzheimer's disease patients. Neurobiology of Aging 25: S377-S378
Press, D.Z.; Casement, M.D.; Schenck, J.F.; Alsop, D.C. 2004: P3-088 High field Mri demonstrates increased brain iron in Alzheimer's disease. Neurobiology of Aging 25: S378-S379
Fennema-Notestine, C.; Archibald, S.L.; Gamst, A.C.; Thal, L.J.; Jernigan, T.L. 2004: P3-091 Regional distribution of white matter changes in Alzheimer's disease. Neurobiology of Aging 25: S379-S380
Tapp, D.; Chu, Y.; Vu, L.; Chiou, J.-Y.; Milgram, N.W.; Nalcioglu, O.; Su, M.-Y. 2004: P3-095 Age-dependent changes in regional brain volume and cerebral blood volume in white matter of the canine brain measured using dynamic susceptibility contrast Mri. Neurobiology of Aging 25: S380-S381
Scheltens, P.; Goekoop, R.; Rombouts, S.A.; Truyen, L.; Barkhof, F. 2004: P3-096 Effects of galantamine challenge on episodic and working memory systems in patients with mild cognitive impairment: an Fmri study. Neurobiology of Aging 25: S381-S382
Park, K.-W.; Kim, J.-W.; Kang, D.-Y.; Kim, T.-Y.; Choi, M.-S. 2004: P3-099 Cerebral blood flow in dementia with lewy bodies using statistical parametric mapping analysis of Tc-99M Hmpao Spect: comparison with Alzheimer's disease. Neurobiology of Aging 25: S382-S383
Prettyman, R.J.; Baillon, S.F. 2004: P3-105 An investigation of autonomic function in Alzheimer's disease and healthy older people using infrared pupillometry and measurement of heart rate and blood pressure. Neurobiology of Aging 25: S384-S385
Norton, M.C.; Steffens, D.C.; Toone, L.; Tschanz, J.T.; Hayden, K.; Corcoran, C.; Klein, L.; Zandi, P.; Breitner, J.C.S.; Welsh-Bohmer, K.A. 2004: P3-108 Late-life depression, mild cognitive impairment, Apoe and their interactive effects on conversion to dementia in a population-based study. The Cache County Study. Neurobiology of Aging 25: S385-S386
Launer, L.J.; Harris, T.B.; Jonsson, P.; Eiriksdottir, G.; Gudnason, V. 2004: P3-115 Ages Reykjavik study: future phenotypes of neurodegeneration. Neurobiology of Aging 25: S387-S388
Li, G.G.; Kukull, W.A.; Peskind, E.; Moore, K.V.; Higdon, R.; Tsuang, D.; van Belle, G.; McCormick, W.; Bowen, J.D.; Teri, L.; Schellenberg, G.D.; Larson, E.B. 2004: P3-117 Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurobiology of Aging 25: S388-S389
Yamada, M.; Mimori, Y.; Kasag, F.; Sasaki, H.; Miyachi, T.; Oshita, T.; Nakamura, S.; Matsumoto, M.; Suzuki, G. 2004: P3-121 Incidence of dementia in a Japanese population: the radiation effects research foundation adult health study. Neurobiology of Aging 25: S389-S390
Laditka, J.N.; Cornman, C.B.; Lane, M.; Porter, C.N.; Davis, D.R. 2004: P3-132 Epidemiology of Alzheimer's disease: race effects, area variation, and clustering. Neurobiology of Aging 25: S392-S393
Razay, G.; Vreugdenhil, A. 2004: P3-136 Alzheimer's disease, abdominal obesity and overweight. Neurobiology of Aging 25: S393-S394
Flicker, L.; Almeida, O.; Acres, J.; Le, M.; Tuohy, R.; Norman, P.; Hankey, G.; Jamrozik, K. 2004: P3-139 Predictors of impaired cognitive function in men over the age of 80 years. Neurobiology of Aging 25: S394-S395
Petitti, D.; Crooks, V.; Buckwalter, G.; Chui, V. 2004: P3-142 Blood pressure levels prior to dementia. Neurobiology of Aging 25: S395-S396
Purandare, N.; Daly, K.J.; Hardicre, J.; Morris, J.; Macfarlane, G.; McCollym, C.N.; Burns, A. 2004: P3-146 Spontaneous cerebral emboli and their association with carotid atherosclerosis and venous to arterial circulation shunt in Alzheimer's disease and vascular dementia. Neurobiology of Aging 25: S396-S397
Debanne, S.M.; Friedland, R.P.; Fritsch, T.; Petot, G.J.; Rowland, D.Y. 2004: P3-149 Alzheimer's disease and smoking: estimation of the competing risk due to smoking-related deaths. Neurobiology of Aging 25: S397-S398
Okereke, O.I.; Hankinson, S.E.; Hu, F.B.; Grodstein, F. 2004: P3-152 Insulin secretion and cognitive function among older women without diabetes. Neurobiology of Aging 25: S398-S399
Laitinen, M.H.; Helkala, E.-L.; Uusitalo, U.; Nissinen, A.; Tuomilehto, J.; Soininen, H.; Kivipelto, M. 2004: P3-155 Midlife dietary fats and the risk of late-life dementia: a population-based study. Neurobiology of Aging 25: S399-S400
Stewart, R. 2004: P3-158 Correlates of memory complaints in 1674 year olds. Data from a large national survey population. Neurobiology of Aging 25: S400-S401
Kuzuhara, S.; Saito, Y.; Murayama, S. 2004: P3-161 Cotton-wool plaques, plaque-like angiopathy, neurofibrillary tangles and leukoencephalopathy in a Japanese man clinically presenting with binswanger's disease. Neurobiology of Aging 25: S401-S402
Xu, D.; Wang, L.; Zhu, M.; Hu, Y.; Gui, Q.; Zhang, H. 2004: P3-165 Relative decrease of capillary density during human brain aging. Neurobiology of Aging 25: S402-S403
Yip, A.G.; McKee, A.C.; Wells, J.; Green, R.C.; Young, H.; Cupples, L.A.; Farrer, L.A. 2004: P3-168 Apoe, vascular pathology, and the Ad brain. Neurobiology of Aging 25: S403-S404
Wang, L.; Zhu, M.; Xie, H.; Gui, Q. 2004: P3-171 Etiology analysis of dementia among 383 Chinese elderly patients with autopsy. Neurobiology of Aging 25: S404-S405
Baloyannis, S.I.; Baloyannis, S.I. 2004: P3-175 Mitochondrial alterations in Alzheimer'sdisease. Neurobiology of Aging 25: S405-S406
Atkinson, L.; Geula, C.; Eskander, M.; Leung, E.; Nagykery, N.; Mirski, D. 2004: P3-179 Rivastigmine: a powerful inhibitor of cholinesterases in plaques and tangles. Neurobiology of Aging 25: S406-S407
Kuchna, I.; Nowicki, K.; Imaki, H.; Wang, K.-C.; Mehta, P.D.; Silverman, W.P.; Reisberg, B.; de Leon, M.; Wisniewski, T.; Pirttila, T.; Frey, H.; Lehtimaki, T.; Kivimaki, T.; Visser, F.E.; Kamphorst, W. 2004: P3-182 Intraneuronal amyloid beta immunoreactivity is not a predictor of fibrillar plaque formation or neurofibrillary degeneration. Neurobiology of Aging 25: S407-S408
Thal, D.R.; Schultz, C.; Botez, G.; Robert, M.E.; Griffin, S.T.; Wiestler, O.D.; Braak, H.; Ghebremedhin, E. 2004: P3-186 Concurrent Alzheimer's disease-related pathology lowers the threshold for developing dementia in argyrophilic grain disease. Neurobiology of Aging 25: S408-S409
Volbracht, C.; van Beek, J.; Leist, M. 2004: P3-202 Neuroprotective properties of memantine in different models of excitotoxicity. Neurobiology of Aging 25: S412-S413
Fluhrer, R.M.; Friedlein, A.; Walter, J.; Haass, C. 2004: P3-205 Phosphorylation of presenilin 1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis. Neurobiology of Aging 25: S413-S414
Duan, Q.; Wang, X.; He, S.; Han, Y. 2004: P3-209 The role of mitochondria in neuron apoptosis during ischemia-reperfusion injury. Neurobiology of Aging 25: S414-S415
Begum, N.N.; Tanaka, T.; Takeda, M. 2004: P3-220 Hyperphosphorylation of tau mediated by innate immune signal tranduction. Neurobiology of Aging 25: S417-S418
Tanimukai, H.; Grundke-Iqbal, I.; Iqbal, K. 2004: P3-224 Inhibitors of protein phosphatase-2A colocalize with the abnormally hyperphosphorylated tau in Alzheimer disease. Neurobiology of Aging 25: S418-S419
Petrucelli, L.; Taylor, J.; Kehoe, K.; Lewis, J.; McGowan, E.; Snyder, H.; Wolozin, B.; Dawson, T.M.; Dillmann, W.; Voellmy, R.; Hutton, M. 2004: P3-228 Chip and Hsp70 regulate tau ubiquitination, degradation and aggregation. Neurobiology of Aging 25: S419-S420
Gorf, K.; Khlistounova, I.; Biernat, J.; Rune, G.; Drexler, D.; Schönig, K.; Bujard, H.; Haemisch, A.; Mandelkow, E.-M. 2004: P3-231 Generation of conditional Tg mice expressing human tau mutants allows studies of formation and reversal of neurofibrillary pathology. Neurobiology of Aging 25: S420-S421
Babu, R.; Wooten, M.W. 2004: P3-235 Characterization of sequestosome/P62-tau-ubiquitin aggregates: tau is a substrate of the Traf6-Ubch7 complex interacting with P62's uba domain. Neurobiology of Aging 25: S421-S422
Grover, A.; Taylor, J.; Hutton, M. 2004: P3-238 Identification of trans-acting factors regulating alternative splicing of tau exon 10. Neurobiology of Aging 25: S422-S423
Kehoe, K.; Taylor, J.; Voellmy, R.; Petrucelli, L.; Hutton, M. 2004: P3-242 Induction of the heat shock response protects against tau associated toxicity in M17 cell lines. Neurobiology of Aging 25: S423-S424
An, W.-L.; Cowburn, R.F.; Bjorkdahl, C.; Braak, H.; Alafuzoff, I.; Iqbal, K.; Grundke-Iqbal, I.; Winblad, B. 2004: P3-246 Association of P70 S6 kinase with neurofibrillary degeneration in Alzheimer's disease. Neurobiology of Aging 25: S424-S425
Wu, C.-K.; Stopa, E.; Geula, C.; Thal, L. 2004: P3-250 Neurofibrillary degeneration is linked with an apoptotic signal - fas-associated death domain in the basal forebrain cholinergic neurons of Alzheimer's disease. Neurobiology of Aging 25: S425-S426
Horsburgh, K.J.; Pickford, F.; Kennedy, L.; Lewis, J.; Hutton, M.; McGowan, E. 2004: P3-253 Temporal alterations in tau and apolipoprotein E after hippocampal denervation in mutant tau mice: a preliminary investigation. Neurobiology of Aging 25: S426-S427
Shepherd, C.E.; Schofield, E.C.; Gregory, G.C.; Halliday, G.M. 2004: P3-260 Non-hyperphosphorylated tau accumulates in the pathological hallmarks in presenilin-1 Alzheimer's disease and frontotemporal dementia. Neurobiology of Aging 25: S428-S429
Hascher, A.; Biernat, J.; Mandelkow, E.-M. 2004: P3-267 Mimicking phosphorylation within the microtubule-binding repeat domain of tau abolishes microtubule binding and Phf formation. Neurobiology of Aging 25: S430-S431
Kuret, J.; Chirita, C.; Congdon, E.; Necula, M.; Yin, H.; Li, G. 2004: P3-271 Mechanism of tau fibrillation in vitro. Neurobiology of Aging 25: S431-S432
Liu, Q.; Smith, M.A.; Siedlak, S.L.; Harris, P.L.; Maccioni, R.B.; Sayre, L.M.; Perry, G. 2004: P3-275 Phosphorylation dependent control of oxidative modification in Alzheimer disease. Neurobiology of Aging 25: S432-S433
Wang, D.; Fujino, Y.; Bennett, D.; Mufson, E.J.; Cochran, E.; Dickson, D.W. 2004: P3-278 Increased tissue transglutaminase correlates with Alzheimer pathology and cognitive status. Neurobiology of Aging 25: S433-S434
Nagele, R.G.; D'Andrea, M.R.; Siu, G.; Venkataraman, V.; Kosciuk, M.C.; Wang, H.-Y. 2004: P3-285 Antibodies targeting the Glu-R2 subunit of the Ampa receptor: a key role for autoimmunity in Alzheimer's disease. Neurobiology of Aging 25: S435-S436
Skandalis, A. 2004: P3-288 The frequency of aberrant Mrna splice variants in sporadic Alzheimer's disease. Neurobiology of Aging 25: S436-S437
Manczak, M.; Park, B.; Jung, Y.; Reddy, P.H. 2004: P3-291 Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neurobiology of Aging 25: S437-S438
Kloskowska, E.; Nilsson, T.; Folkesson, R.; Winblad, B.; Benedikz, E. 2004: P3-294 Activation of the amyloid precursor protein upregulates ornithine decarboxylase expression. Neurobiology of Aging 25: S438-S439
Guan, Z.-Z.; Jin, X.; Shan, K.-R.; Yu, W.-F.; Nordman, T.; Olsson, J.M.; Mousavi, M.; Nordberg, A. 2004: P3-301 Upregulation of alpha7 nicotinic receptor induced by statins involves increased -form of secreted App. Neurobiology of Aging 25: S440-S441
Valenti, D.A.; Laudate, T.M.; Cronin-Golomb, A. 2004: P3-305 Alzheimer's disease and the visual pathway. Neurobiology of Aging 25: S441-S442
Kalke, N.A.; Cook, C.N.; Hejna, M.J.; Magnuson, D.J.; McGuire, S.O.; Lee, J.M. 2004: P3-308 Increase in activated Src: implications for G-protein receptor recycling in Alzheimer's disease. Neurobiology of Aging 25: S442-S443
Gong, B.; Vitolo, O.; Shelanski, M.; Arancio, O. 2004: P3-311 Beta-amyloid protein causes impairment of the ubiquitin-proteasome pathway and synaptic plasticity. Neurobiology of Aging 25: S443-S444
Vaithianathan, T.; Bedi, D.; Patrick, K.M.; Parameshwaran, K.; McMahon, L.L.; Judd, R.L.; Suppiramaniam, V.D. 2004: P3-315 Synaptic Ampa receptor dysfunction: a mechanism for cognitive decline in type-1-diabetic rats. Neurobiology of Aging 25: S444-S445
Tampellini, D.; Almeida, C.G.; Snyder, E.M.; Takahashi, R.H.; Manfredi, G.; Gouras, G.K. 2004: P3-322 Altered expression of synaptic and immediate early genes in a neuronal culture model of Alzheimer's disease. Neurobiology of Aging 25: S446-S447
Miano, J.; Paxia, A.; Li, F.; Ibrahim, J.; Zidovetzki, R.; Brooks, A.; Zlokovic, B. 2004: P3-326 Dysregulation in serum response factor and myocardin in Alzheimer's cerebral arterial system. Neurobiology of Aging 25: S447-S448
Kanno, S.; Nakao, A.; Murase, N.; Billiar, T.R. 2004: P3-329 Carbon monoxide prevents structural deterioration in the hippocampus in hypertensive rats: a novel mechanism of galantamine against vascular related dementia. Neurobiology of Aging 25: S448-S449
Giaccone, G.; Rossi, G.; Fede, G.D.; Marcon, G.; Farina, L.; Sacco, L.; Tagliavini, F. 2004: P3-332 Familial frontotemporal dementia associated with the novel tau mutation T427M. Neurobiology of Aging 25: S449-S450
Kwon, J.C.; na, D.L.; Jung, Y. 2004: P3-336 Fdg-pet findings of semantic dementia: a Spm analysis. Neurobiology of Aging 25: S450-S451
Boeve, B.F.; Tremont, I.W.; Waclawik, A.J.; Murrell, J.; Hermann, B.; Jack, C.R.; Smith, G.E.; Knopman, D.S.; Nair, A.R.; Lindor, N.; Koppikar, V.; Ghetti, B. 2004: P3-339 Longitudinal characterization of two siblings with frontotemporal dementia associated with the S305N tau mutation. Neurobiology of Aging 25: S451-S452
Bogdanovic, N.; Volkmann, I.; Östberg, P. 2004: P3-346 Semantic dementia Unique clinical and neuropathological entity?. Neurobiology of Aging 25: S453-S454
Wang, C.; Kim, J.-I.; Kuizon, S.; Barengolts, D.; Meeker, C.; Kascsak, R.; Carp, R.; Rubenstein, R. 2004: P3-353 A protease resistant Prp isoform in plasma of hamsters infected with the 263K scrapie strain. Neurobiology of Aging 25: S455-S456
Kumar, R.; Lee, I.; Gibson, A.; Hood, L.E.; Carlson, G.A. 2004: P3-356 Use of expression arrays to prioritize and Rnai to test prion incubation time modifier gene candidates. Neurobiology of Aging 25: S456-S457
Kim, Y.-S.; Lee, H.-P.; Jun, Y.-C.; Choi, J.-K.; Kim, J.-I.; Carp, R.I. 2004: P3-359 Activation of mitogen-activated protein kinases (Mapks) in hamster brains infected with 263K scrapie agent. Neurobiology of Aging 25: S457-S458
Oh, J.-M.; Jin, J.-K.; Park, J.-B.; Kim, Y.-S.; Lee, E.; Kim, J.-I.; Carp, R.I. 2004: P3-363 Increased expression of caveolin-3 in the brains of scrapie-infected mice. Neurobiology of Aging 25: S458-S459
Schmidtke, K.; Hüll, M.; Talazko, J. 2004: P3-367 Posterior cortical atrophy variant of Alzheimer's disease?. Neurobiology of Aging 25: S459-S460
Pulliam, L.; Rempel, H. 2004: P3-371 Hiv-1 Tat inhibits neprilysin and elevates amyloid beta. Neurobiology of Aging 25: S460-S461
Fox, C.; Boustani, M.; Maidment, I.; Shetty, V. 2004: P3-374 Systematic review of the acetyl cholinesterase inhibitors in Parkinsons dementia. Neurobiology of Aging 25: S461-S462
Sunyach, C.; Checler, F. 2004: P3-381 Endocytosis-dependent function of cellular prion. Neurobiology of Aging 25: S463-S464
Saez-Valero, J.; Silveyra, M.X.; Cuadrado-Corrales, N.; Marcos, A.; Barquero, M.S.; Calero, M. 2004: P3-384 Decreased level and altered glycosylation of acetylcholinesterase in creutzfeld-jakob lumbar cerebrospinal fluid. Neurobiology of Aging 25: S464-S465
Malkiewicz, K.; Mohammed, R.; Folkesson, R.; Winblad, B.; Szutowski, M.; Benedikz, E. 2004: P3-387 Polychlorinated biphenyls alter expression of Parkinson's disease associated proteins in human neuroblastoma cells and in the rat brain. Neurobiology of Aging 25: S465-S466
Lippa, C.F.; Tahmoush, M.; Mori, H. 2004: P3-396 Alpha-synuclein inclusion formation in pathologic aging: how important is beta-amyloid burden?. Neurobiology of Aging 25: S467-S468
Doody, R.; Pratt, R.D.; Posner, H.; Kumar, D. 2004: P3-402 Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits. Neurobiology of Aging 25: S469-S470
Zhao, Z.; Rostagno, A.; Revesz, T.; Frangione, B.; Ghiso, J. 2004: P3-407 Sirna-mediated Bri2 gene silencing in human neuronal cells. Neurobiology of Aging 25: S470-S471
Goldstein, H.R.; Gold, M. 2004: P4-002 Galantamine in the treatment of patients with mild cognitive impairment: baseline demographics and psychometric testing results. Neurobiology of Aging 25: S472-S473
Tsolaki, M.; Patousi, A.; Vasiliadis, G.; Touliou, A.; Proyia, E.; Papaioannou, A.; Kazis, A. 2004: P4-005 The effect of depression on cortisol levels of patients with or without cognitive impairment. Neurobiology of Aging 25: S473-S474
Villalpando-Berumen, J.M.; Garcia-Cruz, J.C.; Reyes-Guerrero, J.A.; Villa, A.R.; Gutierrez-Robledo, L.M. 2004: P4-011 Long-term survival rates associated with cognitive performance in an elderly Mexican population. Neurobiology of Aging 25: S475-S476
Rozzini, R.; Sabatini, T.; Boffelli, S.; Cassinadri, A.; Trabucchi, M. 2004: P4-018 Delirium in a sub-intensive care unit (Sicu) for elderly patients. Neurobiology of Aging 25: S477-S478
Dunn, J.E.; Stoddard, A.; Zuelsdorf, M.; Banks, S.; Weintraub, S. 2004: P4-025 Mild cognitive impairment (memory loss type) and vitamin E supplement use: an interim analysis. Neurobiology of Aging 25: S479-S480
Schröder, J.; Schönknecht, P.; Pantel, J. 2004: P4-029 Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old individuals in Germany. Neurobiology of Aging 25: S480-S481
Lipton, A.M.; Womack, K.B.; Moore, C.S.; Bottiglieri, T.; Diaz-Arrastia, R. 2004: P4-032 Homocysteine levels are elevated in frontotemporal lobar degeneration. Neurobiology of Aging 25: S481-S482
Woodruff, B.K.; Graff-Radford, N.R.; Ferman, T.J.; Dickson, D.W.; Crook, J.E.; Arvanitakis, Z. 2004: P4-036 Is family history of dementia a risk factor for lewy body dementia. Neurobiology of Aging 25: S482-S483
Kuller, L.H.; Lopez, O.L.; Jagust, W.J.; Becker, J.T.; DeKosky, S.T.; Lyketsos, C.; Kawas, C.; Breitner, J.C.S.; Fitzpatrick, A.; Dulberg, C. 2004: P4-039 Clinical and Mri factors for vascular dementia in the cardiovascular health study cognition study. Neurobiology of Aging 25: S483-S484
Kwok, J.B. 2004: P4-045 Analysis of two candidate genes as late-onset Alzheimer's disease susceptibility loci on chromosome 10Q. Neurobiology of Aging 25: S485-S486
Arboleda, H.; Duarte, N.; Lozano, J.; Pena, M.; Dalila, C.; Yunis, J.; Arboleda, G.; Pardo, R. 2004: P4-052 Screening of mutations in exons 5 and 8 of the presenilin-1 gene in a Colombian sample with early onset Alzheimer's disease. Neurobiology of Aging 25: S487-S488
Hamilton, G.; Samadi, F.; Archer, N.; Foy, C.; Walter, S.; Turic, D.; Jehu, L.; Hollingworth, P.; Jones, S.; Moore, P.; Jones, L.; Williams, J.; Owen, M.; Lovestone, S.; Powell, J. 2004: P4-058 Searching chromosome 10 for an Ad risk factor Analysis of a positional and biological candidate. Neurobiology of Aging 25: S489-S490
Wiener, H.; Go, R.; Perry, R.; Blacker, D.; Bassett, S. 2004: P4-064 Fine mapping of an Ad candidate region on chromosome 9. Neurobiology of Aging 25: S491-S492
Brown, A.M.; Wavrant-DeVrieze, F.S.; Gordon, D.; Lee, H.; Hardy, J.; Blass, J. 2004: P4-066 Independent case-control confirmation of association of Dld with Ad. Neurobiology of Aging 25: S492-S493
Faltraco, F.; Teipel, S.J.; Dodel, R.; Du, Y.; Farlow, M.R.; Shen, Y.; Moeller, H.-J.; Hampel, H. 2004: P4-073 Cdc2 gene polymorphism is associated with cognitive decline in Alzheimer's disease. Neurobiology of Aging 25: S494-S495
Cui, J.G.; Mukherjee, P.K.; Thompson, H.W.; Prescott, S.M.; Carlson, M.; Sato, C.; Salehi-Rad, S.; Rogaeva, E.; StGeorge-Hyslop, P.; Farrer, L.A.; Moliaka, Y.; Grigorenko, A.; Rogaev, E.I.; Bazan, N.G.; Lukiw, W.J. 2004: P4-076 Polymorphism in the cyclooxygenase-2 (Cox-2) and presenilin 2 (Ps2) gene promoters: impact on inflammatory signaling and potential contribution to the etiopathology of Alzheimer's disease (Ad). Neurobiology of Aging 25: S495-S496
Nowotny, P.; Smemo, S.; Hinrichs, T.; Holmans, P.; Tracey, K.; Doil, L.; Grupe, A.; Goate, A. 2004: P4-079 Is variation in the gene encoding insulin-degrading enzyme (Ide) a risk factor in late-onset Alzheimer's disease?. Neurobiology of Aging 25: S496-S497
Engelborghs, S.; Holmes, C.; McCulley, M.; DeDeyn, P.P. 2004: P4-086 5-Ht2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease. Neurobiology of Aging 25: S498-S499
Kim, K.-W.; Suh, Y.-J.; Park, W.-Y.; Jhoo, J.-H.; Lee, D.-Y.; Youn, J.-C.; Seo, J.-S.; Woo, J.-I. 2004: P4-093 Association analysis between choline acetyltransferase (Chat) polymorphism and Alzheimer's disease using a stochastic search variable selection (Ssvs) approach. Neurobiology of Aging 25: S500-S501
Gustafson, D.; Eriksson, E.; Blennow, K.; Skoog, I. 2004: P4-096 Genetic variation in the renin-angiotensin system and risk of Alzheimer's disease. Neurobiology of Aging 25: S501-S502
Gaither, L.A.; Yan-Neale, Y.; Cohen, D. 2004: P4-099 Identification of modifiers of A secretion in Cho cells. Neurobiology of Aging 25: S502-S503
Gilbert, J.R.; Xu, P.-T.; Li, Y.-J.; Qin, X.-J.; Schmechel, D.; Hulette, C.; McLaurin, A.; Scherzer, C.; Gullans, S.R.; Haines, J.L.; Pericak-Vance, M.A. 2004: P4-103 Apoe allele specific gene expression in Alzheimer's and control hippocampus. Neurobiology of Aging 25: S503-S504
Doil, L.; Tacey, K.; Nowotny, P.; van Luchene, R.; Li, Y.; Holmans, P.; Smemo, S.; Garcia, V.; Rowland, C.; Leong, D.; Gogic, G.; Cravchik, A.; Ross, D.; Lau, K.; Catanese, J. 2004: P4-110 A systematic scan of chromosome 10 single nucleotide polymorphisms identifies novel candidate genes showing strong association to Alzheimer's disease. Neurobiology of Aging 25: S505-S506
Bondi, M.W.; Houston, W.S.; Eyler, L.T.; Brown, G.G. 2004: P4-112 Differential bold brain response to verbal paired-associate learning by Apoe genotype in nondemented older adults: a functional Mri study. Neurobiology of Aging 25: S506-S507
Orlacchio, A.; Kawarai, T.; Polidoro, M.; Paterson, A.D.; Rogaeva, E.; Orlacchio, A.; StGeorge-Hyslop, P.H.; Bernardi, G. 2004: P4-115 Molecular analysis of the nicastrin promoter Snps in Alzheimer's disease. Neurobiology of Aging 25: S507-S508
Börjesson Hanson, A.; Blennow, K.; Skoog, I. 2004: P4-118 Is Apoe 4 still a risk factor for dementia in the oldest old? Findings from the 95+ study. Neurobiology of Aging 25: S508-S509
Roberts, S.; Lock, M.; Prest, J.; Barber, M.; Whitehouse, P.; LaRusse, S.; Relkin, N.; Brown, T.; Green, R.C. 2004: P4-121 How does genetic testing affect anxiety about developing ad? Findings from a randomized clinical trial. Neurobiology of Aging 25: S509-S510
McIlroy, S.P.; Craig, D.; Hart, D.J.; Gormley, D.P.; Patterson, C.; Passmore, P.A. 2004: P4-124 The Prnp M129V genetic variant is associated with sporadic Alzheimer's disease in Northern Ireland. Neurobiology of Aging 25: S510-S511
Gerkin, R.; Domb, A.; Lawson, M.; Caselli, R.; Chen, K.; Bandy, D.; Reiman, E. 2004: P4-128 A person's reported history of hypothyroidism is related to apolipoprotein E 4 gene dose. Neurobiology of Aging 25: S511-S512
Minster, R.L.; Desai, P.P.; Öztürk, A.; Chen, Q.; Ganguli, M.; Nebes, R.D.; Reynolds, C.F.; DeKosky, S.T.; Ilyas Kamboh, M. 2004: P4-131 Association of the Apoe promoter polymorphisms with late-onset Alzheimer's disease. Neurobiology of Aging 25: S512-S513
Fakhri, B. 2004: P4-135 Association study on Ide by using single nucleotide polymorphism (Snp). Neurobiology of Aging 25: S513-S514
Katzov, H.; Kehoe, P.G.; Andreasen, N.; Gatz, M.; Wilcock, G.K.; de Faire, U.; Brookes, A.J.; Pedersen, N.L.; Blennow, K.; Prince, J.A. 2004: P4-142 Common variants of Ace contribute to variable age at onset of Alzheimer's disease. Neurobiology of Aging 25: S515-S516
Benussi, L.; Signorini, S.; Ghidoni, R.; Alberici, A.; Barbiero, L.; Feudatari, E.; Gigola, L.; Nicosia, F.; Paterlini, A.; Strom, T.; Bettecken, T.; Meitinger, T.; Binetti, G. 2004: P4-149 Identification of genetic loci associated with familial frontotemporal dementia. Neurobiology of Aging 25: S517-S518
Cruts, M.; Rademakers, R.; Bogaerts, V.; Zee, J.; Pooter, T.D.; Broeck, M.V.; van Duijn, C.M.; Broeckhoven, C.V. 2004: P4-152 The tau gene (Mapt) at chromosome 17Q21 is flanked by low-copy repeats leading to genomic rearrangement. Neurobiology of Aging 25: S518-S519
Anankov, R.V.; Husemann, J.; Silverstein, S.C. 2004: P4-159 Effects of Il-1 and Tnf-A on production of Mcp-1 and nitric oxide by primary adult mouse astrocytes upon interaction with A 142 and Prp 106126. Neurobiology of Aging 25: S520-S521
Sleegers, K.; Koning, I.de; Aulchenko, Y.S.; Croes, E.A.; van Swieten, J.C.; Oostra, B.A.; van Duijn, C.M. 2004: P4-162 Heritability of cognitive function in later adult life in a single extended pedigree. Neurobiology of Aging 25: S521-S522
Chen, J.; Yipeng, H.; Jianzhi, Y.; Wang, L.; Wang, F. 2004: P4-166 Overexpression of Cdk-5 induces hyperphosphorylation of cytoskeletal proteins and impairment of axonal transport in N2A cells. Neurobiology of Aging 25: S522-S523
Zhang, L.; Lee, J.; Song, L.; Terracina, G.; Parker, E.M. 2004: P4-170 Characterization of reconstituted -secretase activity from Sf9 cells co-expressing presenilin-1, Pen-2 nicastrin and Aph-1. Neurobiology of Aging 25: S523-S524
Wang, L.; Kennedy, M.E. 2004: P4-173 Comparison of Nt2 neurons and Hek293 cells as models for studying bace inhibition. Neurobiology of Aging 25: S524-S525
Cook, C.N.; Magnuson, D.J.; Hejna, M.J.; Kalke, N.A.; McGuire, S.O.; Lee, J.M. 2004: P4-184 Altered expression of the calcineurin inhibitor calcipressin in Alzheimer's disease. Neurobiology of Aging 25: S527-S528
Qing, H.; Zhou, W.; Christensen, M.A.; Sun, X.; Tong, Y.; Song, W. 2004: P4-188 Degradation of bace by the ubiquitin-proteasome pathway. Neurobiology of Aging 25: S528-S529
Padberg, I.; Anquez, V.; Cusznir, E.; Muller, F.; Jacobsen, H.; Grüninguer, F.; Adessi, C. 2004: P4-199 Kinetic of degradation of different molecular forms of amyloid beta 42 used as substrate for Nep and Ide. Neurobiology of Aging 25: S531-S532
Richartz, E.R.; Schott, K.J.; Batra, A. 2004: P4-206 Decrease of cellular immune activity: a possible pathogenetic factor in Alzheimer's disease. Neurobiology of Aging 25: S533-S534
Gentleman, S.M.; Leclercq, P.D.; Murray, L.S.; Stewart, J.; Nicoll, J.A.; Graham, D.; Griffin, S. 2004: P4-213 Interleukin-1 genotype and microglial pathology in Alzheimer's disease. Neurobiology of Aging 25: S535-S536
Korolainen, M.A.; Auriola, S.; Nyman, T.; Alafuzoff, I.; Pirttilä, T. 2004: P4-216 Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease brain. Neurobiology of Aging 25: S536-S537
Zhang, W.; Giuseppin, S.; Stanimirovic, D. 2004: P4-220 -amyloid-induced inflammatory gene expression in human brain endothelial cells. Neurobiology of Aging 25: S537-S538
Pelton, G.H.; Moeller, J.; VanHeertum, R.; Chang, R.C.; Michaels, K.; Mensh, B.; Sackeim, H.A.; Waterhouse, R.N.; Devanand, D.P. 2004: P4-223 Peripheral lipopolysaccharide (Lps) administration produces anatomically discrete increases in brain activity measured by [18]Fdg in the rat and regional blood flow by 15O-water in the human. Neurobiology of Aging 25: S538-S539
Wei, X.; Gao, F.; Chen, X.; Dodel, R.; Hampel, H.; Farlow, M.; Du, Y. 2004: P4-226 C/T conversion affects interleukin 1A promoter function in a human astrocyte cell line. Neurobiology of Aging 25: S539-S540
Akterin, S.; Miranda-Vizuete, A.; Winblad, B.; Cowburn, R.F.; Cedazo-Mínguez, A. 2004: P4-233 Beta-amyloid oxidation of thioredoxin and glutaredoxin. A possible link between oxidative stress and apoptosis in Alzheimer's disease. Neurobiology of Aging 25: S541-S542
Jordan-Sciutto, K.L.; Glass, C.A.; Kopp, A.S.; Morgan, K.L.; Koike, M.A. 2004: P4-236 Expression of the antioxidant response transcriptional regulator, Nrf2, in Alzheimer's disease. Neurobiology of Aging 25: S542-S543
Han, S.-H. 2004: P4-248 Ginkgo biloba extract (Egb 761) attenuates ethanol-induced neurotoxicity in Pc12 cells through antioxidative mechanism. Neurobiology of Aging 25: S545-S546
Qiao, W.H.; Hui, C.; Shao, H.Y. 2004: P4-251 Change of App and Ho-1 gene expression in peripheral blood of Alzheimer's disease patients using fluorescence quantitative Rt-Pcr method. Neurobiology of Aging 25: S546-S547
Grimm, M.O.; Grimm, H.S.; Paetzold, A.J.; Zinser, E.G.; Duering, M.; Bruegger, B.; Shen, J.; Hartmann, T. 2004: P4-254 Dual function of -secretase in lipid-homeostasis and A-production. Neurobiology of Aging 25: S547-S548
Arawaka, S.; Koyama, S.; Kato, T. 2004: P4-261 The role of nicastrin domains for assembly of the gamma-secretase complex. Neurobiology of Aging 25: S549-S550
Verdile, G.; Groth, D.; Mathews, P.; George-Hyslop, P.S.; Fraser, P.; Ramabhadran, T.V.; Kwok, J.; Schofield, P.; Carter, T.; Gandy, S.; Martins, R. 2004: P4-265 Baculoviral expressionof the presenilin mutation lacking exon 9 increase levels of an amyloid beta like protein in Sf9insect cells. Neurobiology of Aging 25: S550-S551
Crystal, A.S. 2004: P4-268 Presenilin modulates Pen-2 levels post-translationally by protecting it from proteasomal degradation. Neurobiology of Aging 25: S551-S552
Ma, G.; Li, T.; Price, D.L.; Wong, P.C. 2004: P4-275 Aph-1A is required for presenilin-dependent -secretase activity during mouse embryogenesis. Neurobiology of Aging 25: S553-S554
Saito, S.; Murayama, K.; Takahashi, N.; Tabira, T.; Araki, W. 2004: P4-279 Characteristics of the protein expression of Aph-1. Neurobiology of Aging 25: S554-S555
Brunkan, A.L.; Martinez, M.; Goate, A.M. 2004: P4-283 Endoproteolysis of presenilin-1 is an intramolecular autocatalytic event. Neurobiology of Aging 25: S555-S556
Wang, J.; Beher, D.; Shearman, M.S.; Goate, A. 2004: P4-286 The C-terminal Pal motif in presenilins constitutes part of the gamma-secretase active site pocket. Neurobiology of Aging 25: S556-S557
Kim, D.Y.; MacKenzie Ingano, L.A.; Carey, B.W.; Pettingell, W.; Kovacs, D.M. 2004: P4-290 Voltage-gated sodium channel beta2 subunit is processed by alpha-, beta- and gamma-secretases, generating fragments elevated in Ad brains. Neurobiology of Aging 25: S557-S558
Massey, L.K.; Monteiro, M.J. 2004: P4-294 Mechanisms of presenilin regulation by ubiquilin. Neurobiology of Aging 25: S558-S559
Laudon, H.; Karlstöm, H.; Mathews, P.M.; Farmery, M.R.; Gandy, S.E.; Lundkvist, J.; Lendahl, U.; Näslund, J. 2004: P4-297 Functional domains in presenilin 1: the Tyr-288 residue controls gamma-secretas activity and endoproteolysis. Neurobiology of Aging 25: S559-S560
Georgakopoulos, A.; Litterst, C.; Xu, C.-J.; Wen, P.; Shao, Z.; Robakis, N. 2004: P4-301 Presenilin-1/gamma secretase cleavage of ephrinb ligands and Ephb receptors. Neurobiology of Aging 25: S560-S561
Parent, A.T.; Taniguchi, Y.; Barnes, N.Y.; Sisodia, S.S. 2004: P4-304 Abrogation of presenilin function increases cAmp-dependent synaptic transmission: influence of presenilin-dependent proteolysis of Dcc receptor. Neurobiology of Aging 25: S561-S562
Baki, L.; Shioi, J.; Wen, P.; Shao, Z.; Gama-Sosa, M.; Schwarzman, A.; Neve, R.; Robakis, N.K. 2004: P4-307 Ps1 suppresses apoptosis and prevents Tau hyperphosphorylation via cadherin/Pi3K signaling; effects of Ps1 Fad mutations. Neurobiology of Aging 25: S562-S563
Gu, Y.; Sanjo, N.; Chen, F.; Hasegawa, H.; Petit, A.; Kawarai, T.; Fraser, P.E.; StGeorge-Hyslop, P. 2004: P4-314 Aph-1, nicastrin, presenilin and Pen-2 form multiple complexes with different biological activities. Neurobiology of Aging 25: S564-S565
LaVioie, M.J.; Ostaszewski, B.L.; Fraering, P.C.; Ye, W.; Wolfe, M.S.; Selkoe, D.J. 2004: P4-318 Step-wise assembly of -secretase: presenilin holoprotein binds to the nicastrin-Aph-1 subcomplex prior to the addition of Pen-2. Neurobiology of Aging 25: S565-S566
Morohashi, Y.; Tominari, Y.; Watanabe, N.; Kan, T.; Fuwa, H.; Natsugari, H.; Fukuyama, T.; Tomita, T.; Iwatsubo, T. 2004: P4-322 Presenilin-1 is a molecular target of a dipeptidic -secretase inhibitor, Dapt. Neurobiology of Aging 25: S566-S567
Bussiere, T.; Lee, C.; Schenk, D.; Seubert, P.; Bard, F. 2004: P4-325 Engagement of microglia by anti-A antibodies induces a response that is distinct from an Lps-induced inflammatory response. Neurobiology of Aging 25: S567-S568
Qu, B.; Rosenberg, R.N.; Johnston, S.A. 2004: P4-329 Genetic immunization approach for therapy of Alzheimer's disease. Neurobiology of Aging 25: S568-S569
Siemers, E.; Dean, R.A.; Satterwhite, J.; Farlow, M.R.; Skinner, M.; Ness, D.; May, P.C. 2004: P4-333 Safety, tolerability, and changes in plasma and cerebrospinal fluid amyloid beta concentrations after administration of a functional gamma-secretase inhibitor in healthy volunteers. Neurobiology of Aging 25: S569-S570
Zamora, E.D.; Conant, K.; Hillaire, C.; Handisurya, A.; Kirnbauer, R.; Rudow, G.; Borchelt, D.; Troncoso, J. 2004: P4-343 Papilomarvirus0like particle A vaccine induces specific antibody response, and prevents behavioral impairment in App/Ps1 transgenic mice. Neurobiology of Aging 25: S572-S573
O'Toole, M.; Janszen, D.B.; Slonim, D.K.; Ellis, D.K.; Legault, H.M.; Whitley, M.Z.; Mounts, W.M.; Zuberek, K.; Black, R.S.; Dorner, A.J. 2004: P4-350 Associations between pre-immunization gene expression levels in peripheral blood mononuclear cells (Pbmcs) and post-immunization encephalitis and Igg titer in patients with Alzheimer's disease (Ad) immunized with A42. Neurobiology of Aging 25: S574-S575
Liu, R.; Sierks, M. 2004: P4-354 Anti beta-amyloid (A) Scfv inhibits A aggregation and neurotoxicity. Neurobiology of Aging 25: S575-S576
Farlow, M.R.; Dean, R.A.; Satterwhite, J.; may, P.C.; Siemers, E. 2004: P4-361 Determination of abeta concentrations in serial samples of human cerebrospinal fluid. Neurobiology of Aging 25: S577-S578
Hyde, L.A.; Manfra, D.; McHugh, N.A.; Zhang, Q.; Engstrom, L.; Pinzon-Ortiz, M.C.; Chen, J.; Josien, H.; Clader, J.; Zhang, L.; Parker, E.M.; Higgins, G.A. 2004: P4-364 Rapid in-vivo assessment of therapeutic window of two -secretase inhibitors in transgenic Crnd8 mice. Neurobiology of Aging 25: S578-S579
Asuni, A.A.; Knudsen, E.; Frangione, B.; Wisniewski, T.; Sigurdsson, E.M. 2004: P4-375 Antibody mediated modulation of A induced neurotoxicity in cell culture. Neurobiology of Aging 25: S581-S582
Wenjie, Z.; Pinya, L. 2004: P4-379 Ginsenoside re improved memory impairment in aged rats and mice. Neurobiology of Aging 25: S582-S583
Zhu, A.; Zhang, Z.; Chu, Y.; Masters, C.L.; Li, Q.-X. 2004: P4-383 Ratanasampil effects on beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiology of Aging 25: S583-S584
Gibson, G.L.; Matharu, B.; Parsons, R.B.; Allsop, D.; Austen, B.M. 2004: P4-390 The acetylcholinesterase inhibitor galantamine inhibits in vitro -amyloid aggregation and cytotoxicity. Neurobiology of Aging 25: S585-S586
Poeggeler, B. 2004: P4-398 Neuroprotection by indole and nitrone compounds acting as mitochondrial metabolism modifiers with potent antioxidant activity. Neurobiology of Aging 25: S587-S588
Shin, K.Y.; Park, C.H.; Choi, S.H.; Lee, S.-H.; Kim, H.-S.; Suh, Y.-H. 2004: P4-405 Dehydroevodiaminehcl extracted from evodia rutaecarpa bentham prevents impairment of learning and memory and neuronal loss. Neurobiology of Aging 25: S589-S590
Zhao, L.; Teter, B.; Morihara, T.; Ubeda, O.; Frautschy, S.A.; Cole, G.M. 2004: P4-410 Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade. Neurobiology of Aging 25: S590-S591
Begum, A.N.; Yang, F.; Hu, S.; Beech, W.; Kim, P.; Glabe, C.G.; Cole, G.M.; Frautschy, S.A. 2004: P4-417 The phenolic antioxidant compound curcumin (Curc), and one of its metabolite tetrahydrocurcumin (Thc) prevent A oligomer formation, de-aggregate previously formed oligomers and are neuroprotective against oligomer toxicity. Neurobiology of Aging 25: S592-S593
Wilson, D.M.; Ni, J.; Yeh, L.-A.; Stein, R. 2004: P4-424 Identifying inhibitors of tau polymerization. Neurobiology of Aging 25: S594-S595
Kusumi, M. 2004: P4-430 Plasma homocysteine, serum vitamine C levels and cognitive function. Neurobiology of Aging 25: S596-S597
Danielsson, E.; Eckernäs, S.; Westlind-Danielsson, A.; Nordström, .; Bartfai, T.; Gottfries, C.-G.; Wallin, A. 1988: Vip-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by alzheimer's disease/senile dementia of the Alzheimer type. Neurobiology of Aging 9: 153-162
Woodruff-Pak, D.S.; Steinmetz, J.E.; Thompson, R.F. 1988: Classical conditioning of rabbits 2-1/2 to 4 years old using mossy fiber stimulation as a Cs. Neurobiology of Aging 9: 187-193
Wei, C.-L.; Murray, J.W. 1991: 234Th/238U disequilibria in the Black Sea. Deep Sea Research Part A. Oceanographic Research Papers 38: S855-S873
Saino, T. 1992: 15N and 13C natural abundance in suspended particulate organic matter from a Kuroshio warm-core ring. Deep Sea Research Part A. Oceanographic Research Papers 39: S347-S362
Kaji, M.; Tomonari, T.; Kagawa, M.; Saito, A.; Tsuda, M.; Harada, R.; Kimura, T.; Kitamura, S.; Yano, H.; Okamoto, K.; Niki, M.; Okahisa, T.; Okamura, S.; Takayama, T. 1990: Widespread neogastropod imposex in the north-east Pacific: implications for Tbt contamination surveys. Deep Sea Research Part B. Oceanographic Literature Review 37(12): 1127-1128
Balastegui, A.; Romeu, J.; Clot, A.; Martín, S.R. 1990: A. Physical oceanography. Deep Sea Research Part B. Oceanographic Literature Review 37(6): 501-511
Shankarkumar, U. 2004: Hla-A, -B and -Cw allele frequencies in a Maratha population from Mumbai, India India Mumbai Marathas. Human Immunology 65(9-10): 954-956
Keever, C.A.; Heise, E.R. 1983: The major histocompatibility complex (CyLa) of the cynomolgus monkey. I. Serologic definition of 21 specificities. Human Immunology 7(3): 131-149
Calleja Escudero, J.; DeLaCruz Ruíz, M.; Rivera Ferro, J.; Torrecilla García-Ripoll, J.R.; Fernández del busto, E.; Peral Martínez, J.I. 2000: Orquitis granulomatosa. Actas Urológicas Españolas 24(8): 682-684
Correas Gómez, M.A.; Portillo Martín, J.A.; Martín García, B.; Hernández Rodríguez, R.; Gutiérrez Baños, J.L.; Del Valle Schaan, J.I.; Roca Edreira, A.; Rado Velázquez, M.A.; Hernández Castrillo, A. 2000: Priapismo por trazodona. Actas Urológicas Españolas 24(10): 840-842
Carballido rodríguez, J.A. 2001: 25 aniversario de actas urolgicas espaolas. Actas Urológicas Españolas 25(1): 1-2
Ballesteros Sampol, J.J. 2002: Obstruccin urinaria. Actas Urológicas Españolas 26(10): 715-730
Herrera Puerto, J.; Herrera Flores, J.; Fernández Iglesias, J.; Marreno Calvo, M.; Burguillo Jiménez, N. 2003: Complicacin inusual post-circuncisin. Actas Urológicas Españolas 27(7): 559-561
Pérez Albacete, M.; Pérez Albacete, M. 2005: Historiografa urolgica. Actas Urológicas Españolas 29(1): 1-4
Gómez-Ferrer Lozano, A.; Navarro Antón, J.A.; Sala Aznar, A.; Mola Arizo, M..; Polo i Peris, A.C. 2007: Carcinoma qustico unilocular. Actas Urológicas Españolas 31(7): 792-795
Bustamante Alarma, S.; Carballido Rodríguez, J. 2008: La urodinmica In vitro. Actas Urológicas Españolas 32(2): 169-171
Arce Gil, J.; Arce Terroba, Y.; Angerri Feu, O.; Caffaratti Sfulcini, J.; Garat Barredo, J.M.. 2008: Ganglioneuroma retroperitoneal en la infancia. Actas Urológicas Españolas 32(5): 567-570
Páez Borda, A. 2009: Al fin, Erspc y Plco. Actas Urológicas Españolas 33(6): 615-618
Cara terribas, C.J.; López garcía, A. 2001: Comentarios a la carta: >. Gastroenterología y Hepatología 24(7): 366-367
Piñol, V.; Pagès, M.; Rodríguez-Moranta, F.; Castells, A. 2004: Colonoscopia virtual. Gastroenterología y Hepatología 27(6): 372-376
Enrique Domínguez-Muñoz, J.; Gisbert, J.P. 2015: ltimas novedades presentadas en gastroenterologa. Gastroenterología y Hepatología 38: 1-2
Mena, J.; Cóndor, L. 2004: Higroma qustico. Clínica e Investigación en Ginecología y Obstetricia 31(3): 114-116
Companya, M.M.; Caneta, R.; Serraa, J.E.; Amengualb, E. 2004: Miofibroblastoma intranodular axilar. Clínica e Investigación en Ginecología y Obstetricia 31(10): 362-365
Montero, N. 2003: Dietas enriquecidas y suplementos nutricionales en ancianos hospitalizados. Revista Española de Geriatría y Gerontología 38(4): 226-236
Garrido Barral, A. 2003: Cuidando al cuidador. Revista Española de Geriatría y Gerontología 38(4): 189-191
Bernà, L.; Martín, F.; Javier Mateos, J.; Ortega, M.; Pons, F.; Cunill, C.; Nadal, C. 2001: 153Sm-Edtmp en un paciente afecto de cncer de colon con metstasis sea. Revista Española de Medicina Nuclear 20(2): 130-131
Peñuelas Sánchez, I. 2001: Radiofrmacos Pet. Revista Española de Medicina Nuclear 20(6): 477-498
Ruiz Guijarro, J.A.; Melgarejo Icaza, M.; Ossola Lentati, G.; Martín Jorge, R.; Ordovas Oromendía, A.; Kostvintseva, O. 2001: Tomgrafos Pet. Revista Española de Medicina Nuclear 20(7): 561-574
Martín-Comín, J. 2003: Quo vadis Rem?. Revista Española de Medicina Nuclear 22(6): 365-366
Balsa Bretón, M.ªA.; García-Arroba Muñoz, J. 2004: Sinoviortesis radioisotpica. Revista Española de Medicina Nuclear 23(1): 49-55
Mateos, J.J.; García, J.R.; Setoain, X.; Simó, M.; Soler, M.; Lomeña, F. 2004: Utilidad del [18F] Fdg Pet para diferenciar malignidad de benignidad en tumores pulmonares. Revista Española de Medicina Nuclear 23(4): 287-288
J.Picazo, J. 2001: Internet. Enfermedades Infecciosas y Microbiología Clínica 19(1): 1-2
Tomás Camacho, .; Pallas, E.; Silva, J. 2001: Sinusitis fngica-protozoaria. Enfermedades Infecciosas y Microbiología Clínica 19(8): 399-400
Juan, J.; Picazo, 2002: La revista. Enfermedades Infecciosas y Microbiología Clínica 20(1): 1-2
Manuel Rodríguez-Chinesta, J.; García, F.; Avellanal, D.; Carlos Gainzarain, J. 2003: Ttanos. Curiosidad histrica?. Enfermedades Infecciosas y Microbiología Clínica 21(1): 65-66
Pualomino, J.; Pachón, J. 2003: Aminoglucsidos. Enfermedades Infecciosas y Microbiología Clínica 21(2): 105-115
Pigrau, C. 2003: Oxazolidinonas y glucopptidos. Enfermedades Infecciosas y Microbiología Clínica 21(3): 157-165
José, M.; Elisa, G.-V.; Jordi, V. 2003: Macrlidos, cetlidos y estreptograminas. Enfermedades Infecciosas y Microbiología Clínica 21(4): 200-208
Alós, J.-I. 2003: Quinolonas. Enfermedades Infecciosas y Microbiología Clínica 21(5): 261-268
Pascual, .; Almirante, B.; Martínez-Martínez, L.; Miró, J.M. 2004: 2004: un ao trascendental para Enfermedades Infecciosas Y MicrobiologA ClNica. Enfermedades Infecciosas y Microbiología Clínica 22(1): 1-2
Trilla, A. 2004: Publicar o perecer: perecer por publicar?. Enfermedades Infecciosas y Microbiología Clínica 22(1): 3-5
Miguel Cisneros, J.; Pachón, J. 2004: Tratamiento de la aspergilosis invasiva. Enfermedades Infecciosas y Microbiología Clínica 22(5): 306-307
González-García, A.; Javier Ferreiro, J.; López-Lopategui, M.aC.; Zabartec, M. 2004: Shock sptico con purpura fulminans por Capnocytophaga canimorsus. Enfermedades Infecciosas y Microbiología Clínica 22(5): 309-310
JoséFuster-Ruizdeapodaca, M.; de Benito, E.; Poveda, A.; Rohlfs, I.; Sampedro, E. 2018: Dimensin social del Vih y respuesta estatal. Enfermedades Infecciosas y Microbiología Clínica 36: 10-14
Martìnez, E.; Pulido, F. 2018: Introduccin. Darunavir, cobicistat, emtricitabina y tenofovir alafenamida coformulados en el tratamiento de la infeccin por el Vih. Enfermedades Infecciosas y Microbiología Clínica 36: 1-2
Redondo Calderón, J.L.; de Dios Luna del Castillo, J.; Jiménez Moleón, J.J.; Lardelli Claret, P.; Gálvez Vargas, R. 2000: Evolucin de la mortalidad por accidentes de trfico en Espaa, 19621994. Gaceta Sanitaria 14(1): 7-15
Manzanera, R.; Torralba, L.; Brugal, M.T.; Armengol, R.; Solanes, P.; Villalbí, J.R. 2000: Afrontar los estragos de la herona: evaluacin de diez aos de un programa integral en Barcelona. Gaceta Sanitaria 14(1): 58-66
García de Olalla, P.; Lai, A.; Jansà, J.M.; Bada(†), J.L.; Caylà, J.A. 2000: Caractersticas Diferenciales del Sida en Inmigrantes Extranjeros. Gaceta Sanitaria 14(3): 189-194
Lostao, L.; Regidor, E.; Aïach, P.; Domínguez, V. 2000: Desigualdades sociales en mortalidad por enfermedad isqumica del corazn y por enfermedad cerebrovascular en hombres en Espaa y Francia, 19881990. Gaceta Sanitaria 14(4): 264-267
Albert Cuñat, V.; Maestro Castelblanque, M.E.; Martínez Pérez, J.A.; Monge Jodra, V. 2000: Factores relacionados con la accidentalidad en personas mayores de 65 aos de la provincia de Guadalajara. Gaceta Sanitaria 14(5): 346-355
Pérez Martín, A.; García García, F.J.; Martín Correa, E.; Romero Rizos, L.; Rodríguez Barquero, M.J.; Echevarría Santamaría, I.; García Colmenero, C. 2000: Factores de riesgo de ingreso hospitalario en mayores de 64 aos. Gaceta Sanitaria 14(5): 363-370
Escribà-Agüir, V.; Clemente, I.; Saurel-Cubizolles, M.J. 2001: Factores socioeconmicos asociados al parto pretrmino. Resultados del proyecto Europop en el Estado espaol. Gaceta Sanitaria 15(1): 6-13
Sáez, M.; García-Rafanell, J.M.; Fernández-Real, J.M.; Barceló, M.A.; Saurina, C.; Marqués, A.; Serrà, D.; Girona, R.; Viñets, C.; Andreu, M.; Badosa, P.; Faixedas, D.; Faixedas, M.; Garrido, J.M.; Gómez-Mata, M. 2001: Prevalencia de la obesidad en la poblacin atendida en asistencia primaria de Girona, 19951999. Gaceta Sanitaria 15(2): 95-103
Gómez-Lázaro, R.; del Romero, J.; Castilla, J.; Rodríguez, C.; García, S.; Clavo, P.; Ballesteros, J. 2001: Categoras de exposicin y seroprevalencia del Vih en adolescentes que se realizaron voluntariamente la prueba. Madrid, 19862000. Gaceta Sanitaria 15(3): 202-208
Salvador, J.; Cunillé, M.; Lladonosa, A.; Ricart, M.; Cabré, A.; Borrell, C. 2001: Caractersticas de las gestantes y control del embarazo en Barcelona, 19941999. Gaceta Sanitaria 15(3): 230-236
Ramos, M.; García, R.; Prieto, M.A.; March, J.C. 2001: Problemas y propuestas de mejora en la atencin sanitaria a los inmigrantes econmicos. Gaceta Sanitaria 15(4): 320-326
Moreno, V.; González, J.R.; Soler, M.; Bosch, F.X.; Kogevinas, M.; Borràs, J.M. 2001: Estimacin de la incidencia de cncer en Espaa: perodo 19931996. Gaceta Sanitaria 15(5): 380-388
Vidal-Rodeiro, C.L.; Santiago-Pérez, M.I.; Paz-Esquete, J.; López-Vizcaíno, M.E.; Cerdeira-Caramés, S.; Hervada-Vidal, X.; Vázquez-Fernández, E. 2001: Distribucin geogrfica y temporal del suicidio en Galicia (19761998). Gaceta Sanitaria 15(5): 389-397
Puig-Junoy, J.; Jané, E.; Castells, X.; de la Mata, I. 2002: Cambios recientes en los sistemas de salud en Amrica Latina y perspectivas de futuro. Gaceta Sanitaria 16(1): 2-4
Figueras, J.; Musgrove, P.; Carrin, G.; Durán, A. 2002: Retos para los sistemas sanitarios de Latinoamrica: qu puede aprenderse de la experiencia europea?. Gaceta Sanitaria 16(1): 5-17
Rossi, T.; Murillo Fort, C.; Puente Karolys, J.C. 2002: Transparencia en las adquisiciones del sector pblico: el caso de los hospitales de la Ciudad de Buenos Aires. Gaceta Sanitaria 16(1): 94-104
Redondo Martín, S.; Morquecho Gil, M.; Berbel Hernández, C.; Viña Simón, M.C. 2002: Solicitud y realizacin del test del Vih en atencin primaria. Estudio de la Red de Mdicos Centinelas de Castilla y Len 19901996. Gaceta Sanitaria 16(2): 114-120
Albert, T. 2002: Cmo Escribir artculos cientficos fcilmente. Gaceta Sanitaria 16(4): 354-357
Colomer Revuelta, C.; PeiróPérez, R. 2002: Techos de cristal y escaleras resbaladizas? desigualdades de gnero y estrategias de cambio en Sespas. Gaceta Sanitaria 16(4): 358-360
Cots, F.; Ollé, C.; Varela, J.; Castells, X.; Manzanera, R.; Vall, O. 2002: Perfil de la casustica hospitalaria de la poblacin inmigrante en Barcelona. Gaceta Sanitaria 16(5): 376-384
Fernández Ruiz, M.L.; Bayle, M.S. 2003: Evolucin de la prevalencia de tabaquismo entre las mdicas y enfermeras de la Comunidad de Madrid. Gaceta Sanitaria 17(1): 5-10
Bassols, A.; Bosch, F.; Campillo, M.; Baños, J.E. 2003: El dolor de espalda en la poblacin catalana. Prevalencia, caractersticas y conducta teraputica. Gaceta Sanitaria 17(2): 97-107
Jané, M.; Borrell, C.; Nebot, M.; Pasarín, M.I. 2003: Impacto del tabaquismo y del consumo excesivo de alcohol en la mortalidad de la poblacin de la ciudad de Barcelona: 19831998. Gaceta Sanitaria 17(2): 108-115
Belenes, R. 2003: Un balance personal de 25 aos de gestin sanitaria moderna en el Sistema Nacional de Salud. Gaceta Sanitaria 17(2): 150-156
Alonso, P.L. 2003: Tendencias de la salud internacional: retos y oportunidades para nuestra sociedad. Gaceta Sanitaria 17(3): 175-178
Serra-Sutton, V.; Rajmil, L.; Alonso, J.; Riley, A.; Starfield, B. 2003: Valores poblacionales de referencia del perfil de salud Chip-Ae a partir de una muestra representativa de adolescentes escolarizados. Gaceta Sanitaria 17(3): 181-189
García, A.M. 2003: A nuestros evaluadores, con amor. Gaceta Sanitaria 17(6): 444-445
Martín-Arribas, M.C.; Posada, M.; Terracini, B.; Carballo, F.; Abaitua, I. 2003: Revisin de los aspectos ticos en la investigacin biomdica: la experiencia del Comit de tica del Centro de Investigacin sobre el Sndrome del Aceite Txico y Enfermedades Raras (Cisater). Gaceta Sanitaria 17(6): 512-514
Felícitas Domínguez-Berjón, M.; Borrell, C.; Pastor, V. 2004: Indicadores socioeconmicos de rea pequea en el estudio de las desigualdades en salud. Gaceta Sanitaria 18(2): 92-100
JoséBelza, M.; Clavo, P.; Ballesteros, J.; Menéndez, B.; Castilla, J.; Sanz, S.; Jerez, N.; Rodríguez, C.; Sánchez, F.; del Romero, J. 2004: Condiciones sociolaborales, conductas de riesgo y prevalencia de infecciones de transmisin sexual en mujeres inmigrantes que ejercen la prostitucin en Madrid. Gaceta Sanitaria 18(3): 177-183
Oliván-Gonzalvo, G. 2004: Comparacin entre los nios de etnia gitana e inmigrantes extranjeros ingresados en centros de proteccin por maltrato. Gaceta Sanitaria 18(5): 380-386
Vara, L.; Sangrador, A.; Muñoz, P.; Sanz, S. 2004: Uso de antihipertensivos en Cantabria (19952002): el desfase con las evidencias. Gaceta Sanitaria 18(5): 406-408
Nebot, M.; María García, A. 2004: La investigacin cualitativa en Gaceta Sanitaria: bienvenida y mejor valorada. Gaceta Sanitaria 18(1): 5-6
Nolasco, A.; Melchor, I.; Moncho, J.; García, C.; Verdú, J.; Caballero, P.; Valero, S.; Martínez, P.; Jesús Pérez, M. 2004: Anlisis de la mortalidad en ciudades: resultados en Valencia y Alicante. Gaceta Sanitaria 18(1): 7-15
de Manuel Keenoy, E. 2004: A Patxi Catal. Gaceta Sanitaria 18(1): 76-77
Kovacs, F. 2004: Intervencin neurorreflejoterpica para el tratamiento de las enfermedades mecnicas del raquis. Resultados de una experiencia piloto. Gaceta Sanitaria 18(4): 275-286
Aymerich, M.; Sánchez, E. 2004: Del conocimiento cientfico de la investigacin clnica a la cabecera del enfermo: las guas de prctica clnica y su implementacin. Gaceta Sanitaria 18(4): 326-334
Fontanet, G.; Casellas, F.; Ramón Malagelada, J. 2004: La Unidad de Atencin Crohn-Colitis: 3 aos de actividad. Gaceta Sanitaria 18(6): 483-485
AntóBoqué, J.M. 1987: La Salud Pblica y la Administracin Sanitaria. Gaceta Sanitaria 1: 3-4
CaylàBuqueras, J.A. 1987: La tuberculosis y sus indicadores epidemiolgicos. Gaceta Sanitaria 1(3): 97-100
Alonso Caballero, J.; Maria AntóBoqué, J. 1988: Desigualtats de salut a barcelona. Gaceta Sanitaria 2(4): 4-12
Moreno Iribas, K. 1988: Anlisis descriptivo de las comunicaciones presentadas al ii congreso de salud pblica y administracin sanitaria. Gaceta Sanitaria 2(4): 34-38
Manzanera López, R.; Berenguer Maimó, J.; Picas Vidal, J.M.; Guanyabens Calvet, J. 1988: Factors relacionats amb els consums sanitaris de la poblaci d'una mtua d'afiliaci obligatria (Pamem). Gaceta Sanitaria 2(5): 88-100
Ascaso Terrén, C.; Canela Soler, J.; Sentís Vílalta, J. 1988: Una aproximacin ecolgica a las causas de mortalidad en 14 pases: el ndice de diversidad de shannon. Gaceta Sanitaria 2(8): 224-229
Maria Antó, J. 1988: Gaceta sanitaria 19861988. Balance de una nueva poca. Gaceta Sanitaria 2(9): 265-266
de la Fuente de Hoz, L.; Martínez de la Concha, D.; Lardelli Claret, P.; Masa Calles, J.; Rodríguez-Contreras Pelayo, R.; Bolaños Carmona, J. 1988: La preferencia en la eleccin de las especialidades mdicas en el perodo 19821987. Gaceta Sanitaria 2(9): 276-280
Sicras Mainar, A.; Navarro Artieda, R. 1988: Revisin de la mortalidad hospitalaria en un hospital comarcal. Gaceta Sanitaria 2(9): 286-289
Catalina Moyano Bautista, M.; Delgado Rodriguez, M.; Rodriguez-Contreras Pelayo, R.; López Gigosos, R.; Cueto Espinar, A.; Gálvez Vargas, R. 1989: El cuenid como tcnica de educacin sanitaria en escolares. Gaceta Sanitaria 3(13): 461-466
Moreno Iribas, C.; Maria Antói Boqué, J. 1990: Admisiones a tratamiento por consumo de opiceos y cocana en espaa. Gaceta Sanitaria 4(16): 4-11
Benavides, F.G.; Pérez, S.; Cayuela, A.; Nolasco, A.; Vanaclocha, H. 1990: Razn de aos de vida perdidos evitables: un indicador para identificar exceso de, mortalidad en areas de salud. Gaceta Sanitaria 4(16): 12-17
Aubài Llambrich, J.; Ramon Villalbíi Hereter, J. 1990: Prevencin desde la escuela del uso de tabaco y de arras sustancias adictivas. Gaceta Sanitaria 4(17): 70-75
Maria Ramón Torrell, J.; Serra Majem, L. 1990: Epidemiologa Descriptiva del Cncer Gstrico en Catalua (19831986). Gaceta Sanitaria 4(17): 76-77
Luisa López González, M.; Cueto Espinar, A.; Martínez Cuervo, F.; Luisa Redondo Cornejo, M.; Ramón Suárez González, J.; Secall Mellén, L. 1990: Publicidad y Educacin Sanitaria. Gaceta Sanitaria 4(21): 233-238
Borrell i Thió, C.; Plasència i Taradach, A.; Thiói Fernández de Henestrosa, S.; Martí-Recober, M. 1991: Vigilncia Epidemiolgica de la Mortalitat a Partir Dels Enterraments. Gaceta Sanitaria 5(22): 6-16
Mingot i Lluís, M.; Ruéi Monné, M.; Borrell i Thió, C. 1991: Anys potencials de Vida Perduts: Comparaci de tres Mtodes de clcul. Gaceta Sanitaria 5(22): 21-28
Cayuela, A.; Vioque, J.; Rodríguez-Arce, .; Rojas, M.; Jiménez-Mengíbar, C. 1991: Diferencias Geogrficas de la Mortalidad Por Tumores Digestivos en Espaa, 19801984. Gaceta Sanitaria 5(23): 72-81
Vallescar Piñana, R.; Moreno Aguado, V.; Sarquella Geli, J.; Vilar Subiras, S.; Martin Mateo, M. 1991: Consumo de Tabaco de la Comarca de la Garrotxa. Estudio Comparativo 19821986. Gaceta Sanitaria 5(24): 125-129
Garcia-lbáñez, T.; Sánchez, E.; Bosch, A.; Casabona, J.; Segura, A. 1991: El Sida en la Literatura Mdica Espaola (19851989): Revisin de Seis Publicaciones. Gaceta Sanitaria 5(27): 273-275
Mingot, M.; Borràs, J.M. 1992: Mortalidad diferencial segn el sexo en catalua. Gaceta Sanitaria 6(28): 8-12
Banegas, J.R.; Alberdi, J.C.; Rodríguez-Artalejo, F.; Domínguez, V.; del Rey Calero, J. 1992: Anlisis Edad-Perodo-Cohorte de la Mortalidad Por Cardiopata Isqumica en Espaa 19651985. Gaceta Sanitaria 6(30): 97-104
Zunzunegui Pastor, M.V.; Àngels Rodríguez Arenas, M.; Sarasquets Eizaguirre, C. 1993: Drogadiccin Intravenosa y Riesgo de Infeccin por Vih en Madrid 1990. Gaceta Sanitaria 7(34): 2-11
Castilla, J.; Victoria Zunzunegui, M.; García, E. 1993: Prediccin de la Incidencia Mnima de Sida en Espaa para el Perodo 19921995. Gaceta Sanitaria 7(36): 105-109
Gutiérrez, J.L.; Regidor, E. 1993: Evolucin de la Mortalidad en el Primer Ao de Vida en Espaa (19751988). Gaceta Sanitaria 7(36): 110-115
Marion Buen, J.; Prados Torres, A. 1993: Caractersticas de Los No Respondientes a un Estudio de Seguimiento en Mayores de 65 Aos. Gaceta Sanitaria 7(39): 282-288
Vall Mayans, M.; Victoria Zunzunegui Pastor, M.; Casabona Barbara, J. 1994: Prediccin a Corto Plazo de Los Casos de Sida en Catalua (199194). Gaceta Sanitaria 8(40): 3-10
Peiró, R.; Colomei, C.; Ashton, J.o.h.n.; Álvarez-Dardet, C. 1994: Abortos inducidos en mujeres espaolas en inglaterra y gales (19741988). Gaceta Sanitaria 8(41): 57-62
Sarasqueta Eizaguirre, C.; Victoria Zunzunegui Pastor, M. 1994: Principales causas de mortalidad en jvenes en la comunidad autnoma de madrid: 19901991. Gaceta Sanitaria 8(42): 117-121
Sarría Santamera, A.; Manuel Sendra Gutiérrez, J. 1994: Evolucin de la Tasa de Cesreas en Espaa: 19841988. Gaceta Sanitaria 8(44): 209-214
Agudo, A.; Badia, A.; Martí, M.; Carme Mas, M.; Molist, M. 1994: Supervivencia en Mujeres con Cncer de Mama de un Registro de Tumores Hospitalario (19791991). Gaceta Sanitaria 8(44): 215-221
Latour-Pérez, J.; Gutiérrez-Vicén, T.; López-Camps, V.; Bonastre-Mora, J.; Salvador Giner-Boix, J.; Rodríguez -Serra, M.; Rosado-Bretón, L. 1995: Diferencias de esfuerzo teraputico en razn del nivel socioeconmico en pacientes con infarto agudo de miocardio. Gaceta Sanitaria 9(46): 5-10
Delgado-Rodríguez, M.; Sillero, M. 1995: Revisin: Diseos Hbridos de Estudios de Cohortes y de Estudios de Casos y Controles. Gaceta Sanitaria 9(46): 42-52
Contreras Tejera, A.; Clavero González, G.; Casas Hidalgo, J. 1995: Barreras de comunicacin con el paciente vih + percibidas por el personal sanitario. Gaceta Sanitaria 9(47): 91-100
Gracia SeguíPuntas, M. 1995: La mortalidad infantil legal en la isla de menorca (19501984). Gaceta Sanitaria 9(47): 110-116
Rodríguez-Legido, C. 1995: La medida de la satisfaccin con la atencin en salud: andaluca 19841992. Gaceta Sanitaria 9(50): 311-315